PharmaZell Revenue and Competitors

Raubling,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • PharmaZell's estimated annual revenue is currently $9.6M per year.(i)
  • PharmaZell's estimated revenue per employee is $201,000

Employee Data

  • PharmaZell has 48 Employees.(i)
  • PharmaZell grew their employee count by 4% last year.

PharmaZell's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is PharmaZell?

One Group – Three Offerings The PharmaZell Group is made up of three core brands – PharmaZell, Farmabios and PharmaChol who supply the pharmaceutical industry with Active Pharmaceutical Ingredients and natural source materials. The Group operates production facilities in Germany, Italy and India and enables its companies to secure the industry's supply chain as trusted drug substance suppliers. Over 900 people work for the PharmaZell Group worldwide. Key Group Facts: - More than €170 million revenue in 2018 - Superb annual growth rate over the last decade - A strong and competitive industry leader, ranked among the top three producers for most Pharmazell products - State-of-the-art proprietary, large-scale electrochemical processes - Proprietary enzymatic route of synthesis for cholic acid derivatives The PharmaZell Group portfolio brings together proprietary know-how, hands-on innovation and our commitment to uncompromising quality. Since 1909, we've built our business with a customer-centric focus and a mutual respect for our employees, partners and the environment. We offer: - A Global Network of Expertise: The Group has production sites and employees in pharmaceutical production markets in Germany, Italy and India. - A Trusted Partnership: We take pride in our long-term customer relationships. - A Solution-Oriented Approach: We are an accessible organization, motivated to make things simpler for customers' business. - A Competitive offering: We consistently deliver value and attractive pricing.

keywords:N/A

N/A

Total Funding

48

Number of Employees

$9.6M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PharmaZell News

2022-04-20 - Qualitative Analysis of Mesalazine Market 2022-2028 ...

PharmaZell; Syntese A/S; Cambrex Corporation; Divis Laboratories; Chemi SpA; Ipca Laboratories; Hangzhou Brother; Lianyungang Fengheng Biopharm...

2022-04-19 - Global Ursodeoxycholic Acid Market Size 2022 Top Industry ...

ICE; Mitsubishi Tanabe Pharma; Daewoong Chemical; PharmaZell GmbH; Zhongshan belling; Dipharma Francis; Grindeks; Erregierre; Abil Chempharma...

2022-04-06 - PharmaZell, Novasep merger creates new CDMO, API ...

PharmaZell—a company that specializes in supplying specialty active pharmaceutical ingredients (APIs)—has announced the closing of its...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$77.4M3852%N/A
#2
$160.8M52514%N/A
#3
$122.4M60920%N/A